209 related articles for article (PubMed ID: 20032989)
1. Health-related quality of life assessment in dermatology: interpretation of Skindex-29 scores using patient-based anchors.
Prinsen CA; Lindeboom R; Sprangers MA; Legierse CM; de Korte J
J Invest Dermatol; 2010 May; 130(5):1318-22. PubMed ID: 20032989
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Skindex-16 construct validity in routinely collected psoriasis data: a retrospective analysis of the relationship between overall physician global assessment scores and Skindex-16 and measure discordance.
Hopkins ZH; Kuceki G; Taliercio VL; Snyder AM; Stoddard GJ; Duffin KC; Hess R; Secrest AM
Arch Dermatol Res; 2023 Jul; 315(5):1151-1159. PubMed ID: 36446939
[TBL] [Abstract][Full Text] [Related]
3. Interpretation of quality-of-life scores.
Chren MM
J Invest Dermatol; 2010 May; 130(5):1207-9. PubMed ID: 20393476
[TBL] [Abstract][Full Text] [Related]
4. Factors affecting health-related quality of life in patients with skin disease: cross-sectional results from 8,789 patients with 16 skin diseases.
He Z; Marrone G; Ou A; Liu H; Ma L; Huang Y; Li Y; Sun L; Bai Y; Liu W; Zha X; Lu C
Health Qual Life Outcomes; 2020 Sep; 18(1):298. PubMed ID: 32887630
[TBL] [Abstract][Full Text] [Related]
5. Association between poorer quality of life and psychiatric morbidity in patients with different dermatological conditions.
Sampogna F; Picardi A; Chren MM; Melchi CF; Pasquini P; Masini C; Abeni D
Psychosom Med; 2004; 66(4):620-4. PubMed ID: 15272112
[TBL] [Abstract][Full Text] [Related]
6. Categorization of Skindex-29 scores using mixture analysis.
Nijsten T; Sampogna F; Abeni D
Dermatology; 2009; 218(2):151-4. PubMed ID: 19060458
[TBL] [Abstract][Full Text] [Related]
7. Clinical interpretation of the Uremic Pruritus in Dialysis Patients (UP-Dial) scale: a novel instrument for the assessment of uremic pruritus.
Nochaiwong S; Ruengorn C; Koyratkoson K; Chaisai C; Awiphan R; Thavorn K; Noppakun K; Suteeka Y; Panyathong S; Chongruksut W; Nanta S; Chiewchanvit S;
J Eur Acad Dermatol Venereol; 2018 Jul; 32(7):1188-1194. PubMed ID: 28960570
[TBL] [Abstract][Full Text] [Related]
8. Field performance of the Skindex-17 quality of life questionnaire: a comparison with the Skindex-29 in a large sample of dermatological outpatients.
Sampogna F; Spagnoli A; Di Pietro C; Pagliarello C; Paradisi A; Tabolli S; Abeni D
J Invest Dermatol; 2013 Jan; 133(1):104-9. PubMed ID: 22832497
[TBL] [Abstract][Full Text] [Related]
9. Pictorial Representation of Illness and Self Measure (PRISM): A novel visual instrument to measure quality of life in dermatological inpatients.
Mühleisen B; Büchi S; Schmidhauser S; Jenewein J; French LE; Hofbauer GF
Arch Dermatol; 2009 Jul; 145(7):774-80. PubMed ID: 19620558
[TBL] [Abstract][Full Text] [Related]
10. Clinical meaning in skin-specific quality of life instruments: a comparison of the Dermatology Life Quality Index and Skindex banding systems.
Rogers A; DeLong LK; Chen SC
Dermatol Clin; 2012 Apr; 30(2):333-42, x. PubMed ID: 22284147
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Skindex-29, Dermatology Life Quality Index, Psoriasis Disability Index and Medical Outcome Study Short Form 36 in patients with mild to severe psoriasis.
Fernandez-Peñas P; Jones-Caballero M; Espallardo O; García-Díez A
Br J Dermatol; 2012 Apr; 166(4):884-7. PubMed ID: 22229951
[TBL] [Abstract][Full Text] [Related]
12. Impact of dermatologic adverse events on quality of life in 283 cancer patients: a questionnaire study in a dermatology referral clinic.
Rosen AC; Case EC; Dusza SW; Balagula Y; Gordon J; West DP; Lacouture ME
Am J Clin Dermatol; 2013 Aug; 14(4):327-33. PubMed ID: 23625802
[TBL] [Abstract][Full Text] [Related]
13. Using multiple anchor- and distribution-based estimates to evaluate clinically meaningful change on the Functional Assessment of Cancer Therapy-Biologic Response Modifiers (FACT-BRM) instrument.
Yost KJ; Sorensen MV; Hahn EA; Glendenning GA; Gnanasakthy A; Cella D
Value Health; 2005; 8(2):117-27. PubMed ID: 15804320
[TBL] [Abstract][Full Text] [Related]
14. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
Klassen AF; Miller A; Fine S
Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
[TBL] [Abstract][Full Text] [Related]
15. Further evidence of the validity and reliability of the Skindex-29: an Italian study on 2,242 dermatological outpatients.
Abeni D; Picardi A; Pasquini P; Melchi CF; Chren MM
Dermatology; 2002; 204(1):43-9. PubMed ID: 11834849
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of Skindex-Teen, a quality-of-life instrument for adolescents with skin disease.
Smidt AC; Lai JS; Cella D; Patel S; Mancini AJ; Chamlin SL
Arch Dermatol; 2010 Aug; 146(8):865-9. PubMed ID: 20713817
[TBL] [Abstract][Full Text] [Related]
17. Critical review of generic and dermatology-specific health-related quality of life instruments.
Both H; Essink-Bot ML; Busschbach J; Nijsten T
J Invest Dermatol; 2007 Dec; 127(12):2726-39. PubMed ID: 17989733
[TBL] [Abstract][Full Text] [Related]
18. Quality-of-life assessment in patients with pemphigus using a minimum set of evaluation tools.
Paradisi A; Sampogna F; Di Pietro C; Cianchini G; Didona B; Ferri R; Abeni D; Tabolli S
J Am Acad Dermatol; 2009 Feb; 60(2):261-9. PubMed ID: 19004524
[TBL] [Abstract][Full Text] [Related]
19. Burden of Keloid Disease: A Cross-sectional Health-related Quality of Life Assessment.
Bijlard E; Kouwenberg CA; Timman R; Hovius SE; Busschbach JJ; Mureau MA
Acta Derm Venereol; 2017 Feb; 97(2):225-229. PubMed ID: 27378582
[TBL] [Abstract][Full Text] [Related]
20. Acne vulgaris and the quality of life of adult dermatology patients.
Lasek RJ; Chren MM
Arch Dermatol; 1998 Apr; 134(4):454-8. PubMed ID: 9554297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
